Regrow Biosciences gets USFDA Nod for Phase II trials of ‘OSSGROW’ for Osteonecrosis in the US
OSSGROW is India's first FDA (DCGI) approved product that has treated over 1000 patients across 200 hospitals in the country ...
Tag: Indian-centric global biotech company
From Crisis to Calling: How Varun Chawla Built India’s Most Trusted Business Automation Empire
The phone rang at the worst possible moment. Varun Chawla sat beside his sick son's hospital bed when his office...
Read more
